
Biopharma firm Celgene has appointed Rob Moore as its new Inflammation and Immunology business unit director. Moore has worked in …
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals

